Status:
COMPLETED
An Evaluation of Clotting Factor Activity Before and After Total Hip Arthroplasty
Lead Sponsor:
Military Institute od Medicine National Research Institute
Conditions:
Arthroplasty, Replacement
Coagulation Factors
Eligibility:
All Genders
18+ years
Brief Summary
The objective of the study was to analyze both the concentration and the activity of the clotting factors, D-dimer levels, as well as fibrinogen concentration in patients who underwent primary total h...
Eligibility Criteria
Inclusion
- patients qualified for primary hip arthroplasty for idiopathic osteoarthritis
Exclusion
- hip osteoarthritis because of non-idiopathic etiology
- history of venous thromboembolism or arterial embolism
- anticoagulation treatment,
- coagulopathy
- infection, and
- renal failure defined as a creatinine clearance below 50 ml/minute.
Key Trial Info
Start Date :
February 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04372173
Start Date
February 1 2018
End Date
January 31 2020
Last Update
May 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Intensive Therapy
Warsaw, Poland, 04-141